Fortis Healthcare Ltd (Hospitals) — fundamental analysis, earnings data, and key metrics. PE: 61.0. ROE: 10.1%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on Q3 FY26 (ended December 31, 2025) earnings • Updated Feb 28, 2026
What: 125-bed facility in Bengaluru (expandable to 300 beds) acquired for ₹430 Cr
Impact: +₹150 Cr revenue
“We have completed the acquisition of People Tree Hospitals in Bengaluru for ₹430 Cr, which has 125 operational beds and can be expanded to 300 beds.”
What: Capacity expansion across existing facilities with expected 15-20% revenue growth
Impact: +₹300 Cr revenue
“We plan to add 430+ beds in FY27 through brownfield expansions across our network.”
What: Diagnostic business EBITDA margin expansion from 14.4% to 23.1% in Q3
Impact: +₹50 Cr revenue
“Our diagnostics business reported operating EBITDA margin of 23.1% versus 14.4% in Q3 of financial year 25.”
Earnings deceleration risks from management commentary
Trigger: Continued acquisition-related costs
Impact: -200 bps margin impact
Management view: This resulted in net exceptional loss of ₹46 crores
Monitor: Exceptional items in P&L
Trigger: Integration delays beyond 9 months
Impact: -150 bps margin impact
Management view: Not explicitly addressed
Monitor: Bed occupancy at People Tree
Key quotes from recent conference calls
“We have completed the acquisition of People Tree Hospitals in Bengaluru for ₹430 Cr, which has 125 operational beds and can be expanded to 300 beds. — Dr. Ashutosh Raghuvanshi”
“Our consolidated operating EBITDA increased 34.8% to ₹505 crores which translates into a margin of 22.3%. — Dr. Ashutosh Raghuvanshi”
“Occupied beds rising 14% to 3,189 — Dr. Ashutosh Raghuvanshi”
“We expect continued growth trajectory with 4-5% ARPOB increases going forward. — CFO Vivek Goyal”
Forward-looking targets from management for Next 2-4 quarters
Revenue Growth Target
15%
Implied PAT Growth
15%
OPM Guidance
22.5%
Key Milestones
• 430+ beds addition in FY27
• 20%+ EBITDA margins across 13 facilities
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Feb 28, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Fortis Healthcare Ltd's latest quarterly results (Dec 2025) show
Fortis Healthcare Ltd's current PE ratio is 61.0x.
Fortis Healthcare Ltd's price-to-book ratio is 6.5x.
Fortis Healthcare Ltd's fundamental strength based on key financial ratios
Fortis Healthcare Ltd has a debt-to-equity ratio of N/A.
Fortis Healthcare Ltd's return ratios over recent years
Fortis Healthcare Ltd's operating cash flow is positive (FY2025).
Fortis Healthcare Ltd's current dividend yield is 0.12%.
Fortis Healthcare Ltd's shareholding pattern (Dec 2025)
Fortis Healthcare Ltd's promoter holding has remained stable recently.
Fortis Healthcare Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Fortis Healthcare Ltd has 3 key growth catalysts identified from recent earnings analysis
Fortis Healthcare Ltd has 2 key risks worth monitoring
In Q3 FY26 (ended December 31, 2025), Fortis Healthcare Ltd's management highlighted
Fortis Healthcare Ltd's management has provided the following forward guidance for Next 2-4 quarters
Based on quantitative research signals, here is why Fortis Healthcare Ltd may be worth studying
Fortis Healthcare Ltd investment thesis summary:
Fortis Healthcare Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
